ask="1.400"
ask_size="3700"
average_daily_volume="917956"
bid="1.250"
bid_size="1000"
book_value="1.060"
change="-0.025"
change_from_200_day_moving_average="-1.125"
change_from_50_day_moving_average="0.033"
change_from_52_week_high="-7.625"
change_From_52_week_low="0.335"
change_in_percent="-1.923%"
close="1.275"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.550"
ebitda="-79.23M"
eps_estimate_current_year="-1.340"
eps_estimate_next_quarter="-0.350"
eps_estimate_next_year="-1.070"
ex_dividend_date="N/A"
float_shares="36689000"
high="1.350"
high_52_weeks="8.900"
last_trade_date="3/17/2017"
last_trade_price="1.275"
last_trade_size="10196"
last_trade_time="4:00pm"
low="1.250"
low_52_weeks="0.940"
market_capitalization="67.49M"
moving_average_200_day="2.400"
moving_average_50_day="1.242"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="5.800"
open="1.300"
pe_ratio="N/A"
peg_ratio="-0.020"
percent_change_from_200_day_moving_average="-46.865%"
percent_change_from_50_day_moving_average="+2.657%"
percent_change_from_52_week_high="-85.674%"
percent_change_from_52_week_low="+35.638%"
previous_close="1.300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.226"
price_per_sales="57.631"
revenue="1.19M"
shares_outstanding="52932000"
short_ratio="2.270"
stock_exchange="NGM"
symbol="RGLS"
volume="495442"
weeks_range_52="0.940 - 8.900"
